NCT00414947View on ClinicalTrials.gov

Bioequivalence of Vildagliptin Tablet Manufactured in China Compared to Imported Vildagliptin Tablet in Chinese Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2006

Conditions
Healthy
Interventions
DRUG

Vildagliptin (LAF237)

Trial Locations (1)

Unknown

Novartis Investigative Site, Beijing

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00414947 - Bioequivalence of Vildagliptin Tablet Manufactured in China Compared to Imported Vildagliptin Tablet in Chinese Healthy Volunteers | Biotech Hunter | Biotech Hunter